As recently published on Pressat, Gammora, an innovative HIV treatment developed by Code Pharma, is set to present groundbreaking findings from its clinical trials at two prestigious events later this year.
The first presentation will take place in November 2024 at the HIV Drug Therapy 2024 Conference in Glasgow, Scotland. During this event, Code Pharma will unveil promising early-stage results from clinical trials, highlighting GAMMORA’s unique approach and its potential to reshape HIV treatment.
In December 2024, the spotlight will shift to the HIV Persistence During Therapy Workshop in Miami, Florida, where Code Pharma emphasizes the drug’s potential to revolutionize HIV treatment by targeting the virus in ways not previously seen in existing therapies.